- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01270022
Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk
Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
With this objective this study will be developed in three diferent phases. The guideline in clinical practice elaboration. It will be based in evidence medicine and it will be adapted based in the cardiovascular risk factors guidelines published at the present.
The spreding and implementation of the guideline between the sanitarians, as much in primary medicine as in specialised area, involved in the care of the patient in cardiovascular risk, in the Area 2 in Madrid.
And the evaluation of the implementation strategy, used between the primary care physicians.
For the local adaptation, will be used a systematic review of the different guidelines in the Spanish and international literature, published in the last years about this topic.
The ones with better quality criteria will be selected and doctors and nurses related from different specialities, involved in the cardiovascular illness, as much as members of the staff of the medical management an nursery, will be invited to participate in the selection of the recommendations of the guides and in the search of the consensus. After that, this guide will be given to a group of patients, who will be asked for a critical approach and their suggestions will be applied.
The evaluation will be done with a clinical trial designe , testing the use of the guide and its results on health intermediary variables. With this objective the results with an implementation technique based on opinion leaders plus computer reminder, will be evaluated, instead of using the standard implementation.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28009
- Gerencia de Atención Primaria del área 2
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients whose health cards showed them to belong to the studied health area
Exclusion Criteria:
- Clinical history have not opened in the health center or this one is empty
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Implementation
|
|
Active Comparator: dissemination
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Blanca Novella, MD. pHD, Gerencia de Atención Primaria del área 2
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PI031216
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Risk Factors
-
Federico II UniversityCompleted
-
Fundacio d'Investigacio en Atencio Primaria Jordi...SCMFIC FAMILY DOCTORS CATALAN SOCIETY GRANTCompletedCardiovascular Risk FactorsSpain
-
Hypertension Excellence Centre LucerneRecruiting
-
Kuwait Institute for Medical SpecializationPfizerUnknownCardiovascular Risk Factors
-
University of OxfordBritish Heart Foundation; European Commission; Oxford University Hospitals NHS... and other collaboratorsRecruitingCardiovascular Diseases | Cardiovascular Risk FactorsUnited Kingdom, Germany, Belgium, China, United States, Australia, France, Greece, Hungary, Italy, Japan, Korea, Republic of, Netherlands, Romania, United Arab Emirates
-
Instituto Mexicano del Seguro SocialUniversity of California, Los Angeles; National Council of Science and Technology...CompletedCardiovascular Risk FactorsMexico
-
Milton S. Hershey Medical CenterTerminated
-
University of MichiganNational Institute on Minority Health and Health Disparities (NIMHD)CompletedCardiovascular Risk FactorsUnited States
-
University of British ColumbiaHopeLab Foundation; Social Sciences and Humanities Research Council of Canada; William T. Grant FoundationCompleted
-
Elvir SASBioFortisCompletedCardiovascular Risk FactorsFrance
Clinical Trials on Implementation
-
Yale UniversityNational Institute of Allergy and Infectious Diseases (NIAID); National Heart...CompletedTuberculosis | Tuberculosis, PulmonaryUganda
-
University of PittsburghNational Institute of Mental Health (NIMH)Not yet recruiting
-
Medical University of LodzCompletedChronic Obstructive Pulmonary Disease (COPD)Poland
-
Iowa State UniversityKansas State University; Louisiana State University Health Sciences Center... and other collaboratorsCompletedHealth Promotion | Overweight and Obesity | Sedentary Behavior | Diet, Healthy | Healthy LifestyleUnited States
-
Harvard Medical School (HMS and HSDM)Sangath; Ministry of Health & Family Welfare, IndiaCompletedDepressive Disorder | Depression | Noncommunicable Diseases | PsychologicalIndia
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); Kamuzu University of Health Sciences and other collaboratorsCompleted
-
Boston Medical CenterAgency for Healthcare Research and Quality (AHRQ)Completed
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedHuman Immunodeficiency VirusMalawi
-
VA Office of Research and DevelopmentCompletedTerminal Conditions, End of LifeUnited States
-
Karolinska InstitutetCompleted